Aberrant regulation in the adhesive ability of cancer cells is closely associated with their metastatic activity. In this study, we examine the role of ErbB-2 in regulating the adhesive ability of androgen receptor (AR)-positive human prostate cancer (PCa) cells, the major cell population of PCa. Utilizing different LNCaP and MDA PCa2b cells as model systems, we found that ErbB-2 activity was correlated with PYK2 activity and adhesive ability in those cells. Increased ErbB-2 expression or activity in LNCaP C-33 cells enhanced PYK2 activation and cell adhesion, while the high PYK2 activity and the rapid adhesion of LNCaP C-81 cells were decreased by diminishing ErbB-2 expression or activity. Knockdown studies revealed the predominant role of ErbB-2 in regulating LNCaP C-81 cell adhesion. Coimmunoprecipitation showed that C-81 cells had increased interaction between ErbB-2 and PYK2. Elevated ErbB-2 activity in LNCaP cells correlated with increased ERK/MAPK activity and enhanced adhesive ability, which were abolished by the expression of K457A-PYK2 mutant or the treatment of PD98059, a MEK inhibitor. In summary, our data suggested that ErbB-2, via PYK2-ERK/MAPK, upregulates the adhesive ability of AR-positive human PCa cells.
Introduction
The cell-substratum adhesion plays critical roles in the normal process of cell proliferation, differentiation, migration and survival (Gumbiner, 1996) . Aberrant regulation in the cell-substratum adhesion contributes to the metastatic phenotype of cancer cells (Knudsen and Miranti, 2006) . Although several adhesion-associated proteins have been suggested to be involved in prostate cancer (PCa) cell adhesion, the underlying molecular mechanism is less understood.
Members of the ErbB family, including ErbB-1 (EGFR), ErbB-2 (Her-2/Neu), ErbB-3 and ErbB-4, exhibit various biological activities. Among them, ErbB-2 exhibits an intrinsic tyrosine kinase activity while no ligand has been identified (Hynes and Lane, 2005) . ErbB-2 proteins can be activated by forming homodimers or heterodimers with other members of the ErbB family and transduce their signals through downstream signal molecules (Hynes and Lane, 2005) . The amplification of the erbB-2 gene is found in several human cancers and elevated expression of ErbB-2 protein is strongly correlated with their poor prognosis (Slamon et al., 1989) . In most prostate epithelia, only three members of this family, but not ErbB-4, are expressed (Robinson et al., 1996) . In prostate carcinomas, the erbB-2 gene is not amplified and its protein level is elevated in some advanced tumors during androgen ablation therapy (Signoretti et al., 2000) . In androgen-independent human PCa cells, ErbB-2 is greatly activated by tyrosyl phosphorylation, at least in part due to the low or null expression of cellular prostatic acid phosphatase (cPAcP), a prostate-unique tyrosine phosphatase that dephosphorylates ErbB-2 . Increased ErbB-2 activity in PCa cells correlated with their androgen-independent proliferation, anchorage-independent growth and tumorigenicity (Igawa et al., 2002; Veeramani et al., 2005; Chen et al., 2007) . ErbB-2 may also promote the adhesion of prostate cells (Vafa et al., 1998) while the underlying molecular basis is not understood.
Proline-rich tyrosine kinase 2 (PYK2) is a nonreceptor protein tyrosine kinase structurally related to focal adhesion kinase (FAK) (Schlaepfer et al., 2004) . The tyrosine 402 (Y402) at PYK2, analogous to Y397 in FAK, serves as the primary autophosphorylation site that is essential for PYK2 and c-Src interaction (Avraham et al., 2000) . PYK2 is involved in a variety of cellular activities, for example, in response to integrin-ECM interaction, GPCR activation, stress signals, cytokine stimulation and intracellular calcium elevation (Dikic et al., 1996 (Dikic et al., , 1998 . PYK2 is also involved in regulating the migration and invasion of human glioma as well as breast cancer cells (Zrihan-Licht et al., 2000; Lipinski et al., 2005) . In PCa cells, PYK2 is involved in regulating the activity of androgen receptor (AR) (Wang et al., 2002) .
In this communication, we investigate the intracellular signaling that regulates the adhesive ability of ARpositive PCa cells, the major cell population of PCa, onto the non-coated substratum. Our data clearly showed a novel signaling pathway of ErbB-2-PYK2-ERK/MAPK, which can function as an inside-out signaling to upregulate the adhesive ability of ARpositive human PCa cells.
Results
Correlation of the adhesive ability and the activities of ErbB-2 and PYK2 in AR-positive PCa cells To investigate the molecular mechanism that regulates the adhesive ability of AR-positive PCa cells, we utilized different passages of LNCaP and MDA PCa2b cells as our model systems. As shown in Figure 1a , the adherent cells spread their processes, which were clearly seen at both 3 and 6 h time points after seeding. Further, we compared the relative ratios of adhesion between LNCaP C-33 and C-81 cells. As shown in Figure 1b , the adhesive ratios of C-33 and C-81 cells at 3 h time point were 114.277.5 and 215.174.4% (***Po0.0005, n ¼ 2 Â 3), respectively. The ratios of both cells at 6 h time point were 171.179.8 and 251.473.0% (**Po 0.005, n ¼ 2 Â 3), respectively. We examined the molecular mechanism by analysing the activities of ErbB-2 and FAK family members. As shown in Figure 1c , ErbB-2 activity, as indicated by its Y1248 phosphorylation level, increased upon passage of LNCaP cells, while the low level of ErbB-2 phosphorylation in PC-3 cells is due to a low level of ErbB-2 protein (Figure 1c) . Interestingly, upon passage of LNCaP cells, the PYK2 protein level and its Y402 phosphorylation increased, correlated with their adhesion, while the FAK protein level decreased and its Y397 phosphorylation was very low (Figures 1b and c) . As a positive control for FAK activity, PC-3 cells expressed a high level of FAK protein with a very high level of phosphorylated Y397, while it expressed a low level of PYK2 protein with an undetectable phosphorylation level ( Figure 1c) . Thus, the activities of both ErbB-2 and PYK2, but not FAK, were correlated with the adhesive ability of LNCaP cells.
To clarify whether it is a unique phenomenon in LNCaP cells, we examined the correlation between the activation status of ErbB-2, as well as PYK2 and the adhesive ability in MDA PCa2b cells. Similar correlative results were observed among different passages of MDA PCa2b cells, in which higher passage (p80) cells attached faster than lower passage (p40) cells. The adhesive ratios of p40 and p80 of MDA PCa2b cells at 3 h time point were 102.678.2 and 10571.6% (n ¼ 2 Â 3), respectively while the ratios of both cells at 6 h time point were 11072.7 and 132.476.6% (*Po0.05, n ¼ 2 Â 3), respectively ( Figure 1d) . Further, the adhesive abilities of MDA PCa2b cells correlated with their ErbB-2 and PYK2 activities as well as PYK2 protein expression (Figure 1e ). Thus, increased ErbB-2 and PYK2 activities were in parallel with the rapid adhesion of high-passage LNCaP C-81 and MDA PCa2b cells.
Role of ErbB-2 in regulating the PYK2 activity and the adhesion of LNCaP cells
To define the role of ErbB-2 in regulating PYK2 activity as well as cell adhesion, we utilized LNCaP cells as our model system due to the difficulties of culturing and transfecting MDA PCa2b cells. As shown in Figure 2a (left panel), compared to the vector alone-transfected cells, elevated expression of exogenous ErbB-2 protein in C-33 cells, as indicated by increased Myc epitope expression, concurred with PYK2 activation in those transfectants, following a dose-dependent manner. Elevated ErbB-2 expression in C-33 cells led to an increased adhesion, and the adhesive ratios of vector and ErbB-2 cDNA-transfected C-33 cells at 3 h time point were 97.978.6 and 285.4749.4% (*Po0.01, n ¼ 2 Â 4), respectively (Figure 2a, right panel) .
Alternatively, LNCaP C-33 cells were transiently transfected with siRNA oligomers to cPAcP. Preliminary data showed that in PAcP siRNA oligomertransfected cells, tyrosyl phosphorylation of ErbB-2 and PYK2 increased, higher than that in the scrambled control siRNA oligomer-transfected cells (Veeramani et al., 2005) . We established PAcP-knockdown stable subclones in C-33 cells and analysed their adhesion. As shown in Figure 2b (left panel), in three PAcP-knockdown stable subclone cells, decreased cPAcP levels inversely correlated with increased ErbB-2 and PYK2 activities in a dose-dependent manner. The adhesive ratios of scrambled control and siPAcP-1, -11 and -9 stable subclones at 3 h time point were 104.173.8, 115.972.8, 126.377.1 and 130.276 .2% (*Po0.05, n ¼ 2 Â 4), respectively. Correspondingly, the PYK2 activity correlated with those cell adhesion (r ¼ 0.955, Po0.05).
We determined the effects of reduced ErbB-2 expression on PYK2 activation and cell adhesive ability by establishing ErbB-2-knockdown stable subclones of LNCaP C-81 cells. As shown in Figure 3a (left panel), compared to control cells, ErbB-2-knockdown stable subclone cells expressed decreased ErbB-2 protein.
The adhesive ratios of scrambled control as well as siErbB2-7, -22 and -1 stable subclone cells at 3 h time point were 99.972.0, 92.476.2, 78.872.6 and 69.67 4.6% (*Po0.001, n ¼ 2 Â 4), respectively. Thus, ErbB-2-knockdown subclone cells exhibit reduced PYK2 activation and diminished cell adhesion, despite that these cells expressed similar levels of EGFR and ErbB-3 as control cells. Importantly, the reduced PYK2 activity in those cells significantly correlated with their decreased adhesion (r ¼ 0.963, Po0.05). Additionally, in C-81 cells, in the presence of ErbB-2 inhibitor AG879, the tyrosyl phosphorylation levels of ErbB-2 and PYK2 diminished concurrently with reduced cell adhesion. We established stable subclones of LNCaP C-81 cells whose both EGFR and ErbB-3 expression was knocked down by siRNA. As shown in Figure 4 (left panel), EGFR and ErbB-3 double-knockdown stable subclone cells had PYK2 activities similar to those of control stable subclone cells, despite the fact that their EGFR and ErbB-3 expression levels were greatly reduced. In addition, the adhesive ratios of scrambled control as well as siErbB1/3-6, -20 and -10 stable subclone cells at 3 h time point were 98.272.0, 106.473.3, 99.478.7 and 104.874 .6% (n ¼ 2 Â 3), respectively ( Figure 4, right panel) . Collectively, these data suggested a novel, functional role of ErbB-2 in upregulating the PYK2 activity and the adhesive ability of LNCaP cells.
Interaction of ErbB-2 and PYK2 in AR-positive PCa cells
We examined whether ErbB-2 and PYK2 are in the same functional complex. As shown in Figure 5a (upper panel), C-81 cells exhibited a higher level of the ErbB-2/ PYK2 co-immunoprecipitation (co-IP) than C-33 cells. The differential ErbB-2/PYK2 co-IP in both cells was further observed by reciprocal immunoprecipitation. As shown in the lower panel of Figure 5a , PYK2 was coimmunoprecipitated with ErbB-2, which is clearly seen in C-81 cells but not in C-33 cells. ErbB-2/PYK2 co-IP was also observed in high-passage MDA PCa2b cells, but not low-passage MDA PCa2b cells and CWR22Rv1 cells, two androgen-independent ARpositive PCa cells (Figure 5b ). The data collectively suggested that ErbB-2 and PYK2 are in the same functional complex in AR-positive PCa cells, and the ErbB-2/PYK2 complex is higher in androgen-independent cells, compared to the corresponding androgensensitive cells. 
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Effect of PYK2 on ErbB-2-promoted cell adhesion To determine the role of PYK2 in ErbB-2 signaling for upregulating the adhesive ability and the activity of downstream signaling molecules, LNCaP C-33 cells were co-transfected with cDNAs encoding the wt ErbB-2 and the K457A-PYK2 mutant protein. As shown in Figure 6 (upper panel), compared to the vector alonetransfected cells (lane 1), elevated ErbB-2 expression increased activities of PYK2 and its downstream molecules including ERK/MAPK, p38/MAPK and c-Src, while it had no effect on paxillin activation (lane 2). Importantly, only ErbB-2-activated ERK/MAPK, but not p38/MAPK or c-Src, activity can be abolished by the coexpression of the K457A-PYK2 mutant, following a dose-dependent manner (lanes 4-6), while the K457A-PYK2 alone-transfected cells had no effect on the basal ERK/MAPK activity (lane 3 vs lane 1). The adhesive ratios of vector-, ErbB-2-, K457A-and Figure 1B) . Thus, PYK2 is required for ErbB-2-increased ERK/MAPK activation and adhesion of LNCaP cells.
Effect of MEK inhibitor on the adhesion of LNCaP C-81 cells
We further examined the role of ERK/MAPK in ErbB-2/PYK2-promoted adhesion by treating LNCaP C-81 cells with PD98059, a MEK inhibitor, because C-81 cells exhibited activated ERK/MAPK (Supplementary Figure 2) and faster adhesion (Figure 1c ), compared to C-33 cells. As shown in Figure 7 (left panel), in the presence of PD98059, the activity of ERK/MAPK, but not PYK2, diminished following a dose-dependent manner. Furthermore, the adhesive ratios of 0, 5 and 10 mM PD98059-treated C-81 cells at 3 h time point were 106.572.8, 93.2716.3 and 72.972 .9% (*Po0.05, n ¼ 2 Â 2), respectively ( Figure 7, right panel) . Nevertheless, p38/MAPK inhibitor SB203580 or c-Src inhibitor PP2 had no effect on the PYK2 phosphorylation and the adhesive ability (Supplementary Figure 3A and 3B). The data collectively suggested that ERK/MAPK plays an important role in regulating the adhesion of LNCaP C-81 cells.
Discussion
The adhesive ability of tumor cells to substrata plays a critical role for a successful metastasis (Haier and Nicolson, 2001) . In this study, we investigate a molecular mechanism of the inside-out signaling that regulates the adhesive ability of AR-positive PCa cells utilizing non-coated substrata. Our data revealed a novel signal pathway by which ErbB-2 activates the PYK2-ERK/MAPK pathway to facilitate the adhesive The adhesive ability of androgen receptor-positive human prostate cancer cells T-C Yuan et al ability of AR-positive PCa cells, which potentially contributes to the metastasis of those PCa cells. Despite intensive studies of ErbB-2 in tumorigenesis, the role of ErbB-2 in cell adhesion requires further investigations. Our data showed that ErbB-2 signaling upregulates the adhesive ability of LNCaP cells to noncoated substrata, which is mediated by a mechanism closely associated with the activation of PYK2. Furthermore, our data demonstrated a functional complex formation between ErbB-2 and PYK2. Since both high passages of LNCaP C-81 and MDA PCa2b cells had higher levels of ErbB-2/PYK2 functional complexes than corresponding low passage cells, it suggested that the association of ErbB-2 with PYK2 in the same complex is critical for PYK2 activation and its regulation of cell adhesion. Although c-Src may serve as a mediator for ErbB-2/PYK2 interaction in 293T cells (Zrihan-Licht et al., 2000) , inhibition of c-Src in C-81 cells has no effect on PYK2 activity and the initial adhesion (Supplementary Figure 3B) . Further, the K457A-PYK2 mutant can still activate c-Src, while it inhibits ErbB-2-promoted adhesion ( Figure 6 , Supplementary Figure 1B ). The data suggest that c-Src is not involved in ErbB-2-regulated PYK2 activation as well as adhesion in LNCaP cells. Further experiments are required to clarify if other molecule(s) is involved in the ErbB-2/PYK2 complex formation.
Results from siRNA-knockdown experiments revealed the predominant role of ErbB-2 in regulating the PYK2 activity and the adhesive ability of LNCaP cells. Additionally, EGF or heregulin had no effect on promoting the adhesive ability of C-33 cells (Supplementary Figure 4 ). We propose that in androgenindependent, AR-positive PCa cells, ErbB-2 protein is constitutively activated and/or elevated as seen in clinical samples due, in part, to the loss or null of cPAcP expression (Signoretti et al., 2000; Veeramani et al., 2005) . In those advanced PCa cells, signal pathways initiated by highly activated ErbB-2 lead to a sustained activation of PYK2 and PYK2-mediated functions, which differs from the transient effect activated by ErbB ligands (Zrihan-Licht et al., 2000; van der Horst et al., 2005; Park et al., 2006) . Further investigation for the detailed molecular mechanism of ErbB-2 activation is required.
The involvement of PYK2 in the adhesive ability of AR-positive PCa cells is clearly evident that PYK2 is predominantly expressed in those cells (Supplementary Figure 5A ) and its expression and activity can be upregulated by androgens, correlating with increased adhesion (Supplementary Figure 5B) . Despite that further study is required, these results suggest an important role of AR in regulating PYK2 expression in PCa cells. Additionally, LNCaP cells express an inactive form of FAK (Tremblay et al., 1996) . PYK2-mediated functions are carried out by activating multiple downstream signaling molecules, including ERK/ MAPK (Lev et al., 1995) , p38/MAPK (Pandey et al., 1999) , c-Src (Dikic et al., 1996) and paxillin (Li and Earp, 1997) , which lead to the differential regulation of cell adhesion in different cell types. While elevated ERK/MAPK, p38/MAPK and c-Src activities are correlated with increased PYK2 activity and enhanced adhesion in C-81 as well as PYK2 cDNA-transfected C-33 cells (Supplementary Figure 1A and 2), only ERK/ MAPK activity was consistently reduced by expressing the Y402F or the K457A-PYK2 mutants in C-81 cells, correlated with a decreased adhesion (Figure 6 , Supplementary Figure 1B) . Interestingly, those K457A mutant proteins still exhibit functional Y402 which led to c-Src activation, as described in osteoclasts-like cells (Lakkakorpi et al., 2003) . Thus, PYK2 activates ERK/MAPK and c-Src by differential mechanisms, in which ERK/ MAPK activation depends on both Y402 phosphorylation and kinase activity, while c-Src activation only requires Y402 phosphorylation.
Accordingly, as shown in Figure 8 , ErbB-2 is constitutively activated in AR-positive, androgen-independent PCa cells and at that state, it can activate PYK2 activity, which leads to ERK/MAPK activation and upregulates the adhesive ability of those cells. Our results thus reveal a novel signal pathway that regulates the adhesive ability of AR-positive, androgen-independent PCa cells and provides potential targets for advanced PCa therapy.
Materials and methods

Materials
Abs against pY402-PYK2, pY397-FAK, pY118-paxillin and pY418-c-Src were from BioSources (Camarillo, CA, USA). The Ab against pY1248-ErbB-2 was from Upstate Biotechnology (Lake Placid, NY, USA). The Abs against The adhesive ability of androgen receptor-positive human prostate cancer cells T-C Yuan et al phospho-ERK1/2 and phospho-p38 were from Cell Signaling (Beverly, MA, USA). Other Abs were from Santa Cruz (Santa Cruz, CA, USA) and Sigma (St Louis, MO, USA). Inhibitors were purchased from Calbiochem (San Diego, CA, USA). The cDNAs encoding the wt PYK2 protein or K457A mutant were kindly provided by Dr Chawnshang Chang at URMC (Rochester, NY, USA). The pcDNA3-PYK2(Y402F)-Myc and pcDNA3-HER2-Myc plasmids were generated as described previously (Li et al., 1999; Meng et al., 2000) .
Cell culture and transfection
The culturing of LNCaP, PC-3, DU 145 and CWR22Rv1 cells and the defining of different passages of LNCaP have been described previously Igawa et al., 2002) . MDA PCa2b cells were maintained as described previously (Chen et al., 2007) . For AG879 treatment, LNCaP C-81 cells were incubated for 48 h in a steroid-reduced (SR) medium followed by AG879 treatment in an SR condition for another 16 h. Transient transfection were performed using Lipofectamine and plus reagents for LNCaP cells as described previously (Meng et al., 2000) . Preparation of siRNAs and establishment of siRNA-knockdown stable subclones The design of siRNA essentially followed the protocol from the pSUPER RNAi System (OligoEngine, Seattle, WA, USA).
Cell adhesion assay
The pSUPER vector was used for the expression of siRNA in cells. The PAcP siRNA duplex (target 5 0 -GTGTACTAGC CAAGGAGTT-3 0 ), ErbB-2 siRNA duplex (target 5 0 -AC CTGGAACTCACCTACCT-3 0 ) and EGFR/ErbB-3 siRNA duplex (target 5 0 -CCAATACCAGACACTGTAC-3 0 ) were analysed by Gene Blast searches. Control vector was ligated with scrambled oligonucleotides. For the establishment of siRNA-knockdown or scrambled control stable subclones, cells were transfected with the pSUPER expression vector containing corresponding siRNA-expressing sequence or scrambled oligonucleotides. The transfected cells were selected by geneticin.
Western blot analysis and immunoprecipitation
The conduction of western blot analysis and immunoprecipitation has been described previously .
Semi-quantitative analysis
The relative expression and phosphorylation levels of proteins were semi-quantified by Gel Doc EQ Gel Documentation System (Bio-Rad Laboratories, CA, USA). The relative ratios of phosphorylation level to its protein level were calculated and then normalized to that of control cells.
Statistical analysis
Differences between the adhesion ratios of cells were evaluated by using Student's t-test. The difference was considered significant when the P-value was less than 0.05. The relationship between the relative ratios of adhesion and PYK2 phosphorylation was evaluated by their correlation coefficient (r). The correlation was considered significant when the P-value was less than 0.05.
